Financière de Tubize is a Belgian holding company whose principal asset is a substantial long-term stake in UCB, the biopharmaceutical group known for neurology and immunology medicines. It does not operate drug discovery or manufacturing itself; its value is tied to ownership and governance influence in UCB. Investors use it as a listed vehicle for concentrated exposure to that single underlying biopharma franchise.
| Year | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| 2022 | 0 | — | 85.2 | — |
| 2023 | 0 | — | 88.2 | 3.5% |
| 2024 | 0 | — | 90.1 | 2.2% |
| 2025 | 0 | — | 93.2 | 3.5% |
All markets — KeepWinning global stock screener
Other companies on Euronext Brussels: Syensqo SA/NV (SYENS), KBC Ancora SA (KBCA), Umicore SA (UMI), Aedifica NV/SA (AED), Warehouses De Pauw SA (WDP), Cenergy Holdings SA (CENER)